CAR T-cells
Weaponised CAR T-cell therapy eradicates prostate tumours in mice
Von KI berichtet
Researchers have developed a modified CAR T-cell therapy that completely eliminated large solid prostate tumours in mice, offering hope for treating solid cancers in humans. The approach localises immune-stimulating proteins to tumours, avoiding damage to healthy tissues. Clinical trials could begin within two years.